BIOFIL CHEMICALS & PHARMACEUTICALS
|
BIOFIL CHEMICALS & PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹40 Cr | ₹30 Cr | ₹22 Cr | ₹36 Cr | ₹30 Cr |
Sales | ₹40 Cr | ₹30 Cr | ₹22 Cr | ₹34 Cr | ₹27 Cr |
Job Work/ Contract Receipts | - | - | ₹0.56 Cr | ₹1.80 Cr | ₹2.30 Cr |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹40 Cr | ₹30 Cr | ₹22 Cr | ₹36 Cr | ₹30 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-0.27 Cr | ₹-0.20 Cr | ₹3.59 Cr | ₹-2.77 Cr | ₹-0.34 Cr |
Raw Material Consumed | ₹38 Cr | ₹28 Cr | ₹16 Cr | ₹35 Cr | ₹26 Cr |
Opening Raw Materials | ₹0.68 Cr | ₹0.96 Cr | ₹0.43 Cr | ₹0.54 Cr | ₹0.38 Cr |
Purchases Raw Materials | ₹6.31 Cr | ₹3.64 Cr | ₹2.80 Cr | ₹6.74 Cr | ₹4.22 Cr |
Closing Raw Materials | ₹1.73 Cr | ₹0.68 Cr | ₹0.96 Cr | ₹0.43 Cr | ₹0.54 Cr |
Other Direct Purchases / Brought in cost | ₹33 Cr | ₹24 Cr | ₹14 Cr | ₹28 Cr | ₹22 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹0.38 Cr | ₹0.33 Cr | ₹0.30 Cr | ₹0.29 Cr | ₹0.49 Cr |
Electricity & Power | ₹0.38 Cr | ₹0.33 Cr | ₹0.30 Cr | ₹0.29 Cr | ₹0.49 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹0.50 Cr | ₹0.45 Cr | ₹0.79 Cr | ₹0.75 Cr | ₹0.86 Cr |
Salaries, Wages & Bonus | ₹0.41 Cr | ₹0.37 Cr | ₹0.68 Cr | ₹0.64 Cr | ₹0.74 Cr |
Contributions to EPF & Pension Funds | ₹0.06 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.06 Cr |
Workmen and Staff Welfare Expenses | ₹0.00 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.03 Cr |
Other Employees Cost | ₹0.03 Cr | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.03 Cr |
Other Manufacturing Expenses | ₹0.31 Cr | ₹0.16 Cr | ₹0.15 Cr | ₹0.30 Cr | ₹0.55 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹0.00 Cr | ₹0.00 Cr | ₹0.03 Cr | ₹0.16 Cr | ₹0.31 Cr |
Repairs and Maintenance | ₹0.15 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.06 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹0.16 Cr | ₹0.11 Cr | ₹0.06 Cr | ₹0.09 Cr | ₹0.18 Cr |
General and Administration Expenses | ₹0.41 Cr | ₹0.41 Cr | ₹0.30 Cr | ₹0.29 Cr | ₹0.24 Cr |
Rent , Rates & Taxes | - | - | - | - | - |
Insurance | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr |
Printing and stationery | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.02 Cr |
Professional and legal fees | ₹0.18 Cr | ₹0.18 Cr | ₹0.22 Cr | ₹0.21 Cr | ₹0.18 Cr |
Traveling and conveyance | ₹0.03 Cr | ₹0.04 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr |
Other Administration | ₹0.18 Cr | ₹0.18 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.01 Cr |
Selling and Distribution Expenses | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.38 Cr |
Advertisement & Sales Promotion | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Sales Commissions & Incentives | - | ₹0.01 Cr | - | ₹0.00 Cr | ₹0.37 Cr |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹0.11 Cr | ₹0.08 Cr | ₹0.05 Cr | ₹0.08 Cr | ₹0.03 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.11 Cr | ₹0.08 Cr | ₹0.05 Cr | ₹0.08 Cr | ₹0.03 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹39 Cr | ₹29 Cr | ₹21 Cr | ₹34 Cr | ₹28 Cr |
Operating Profit (Excl OI) | ₹0.82 Cr | ₹1.17 Cr | ₹1.33 Cr | ₹1.60 Cr | ₹1.82 Cr |
Other Income | ₹0.49 Cr | ₹0.10 Cr | ₹0.15 Cr | ₹0.80 Cr | ₹0.17 Cr |
Interest Received | ₹0.01 Cr | ₹0.00 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | ₹0.00 Cr | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | - | - | - | - | - |
Others | ₹0.48 Cr | ₹0.10 Cr | ₹0.13 Cr | ₹0.78 Cr | ₹0.15 Cr |
Operating Profit | ₹1.31 Cr | ₹1.27 Cr | ₹1.48 Cr | ₹2.40 Cr | ₹2.00 Cr |
Interest | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.07 Cr | ₹0.12 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Other Interest | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.06 Cr | ₹0.12 Cr |
PBDT | ₹1.27 Cr | ₹1.22 Cr | ₹1.44 Cr | ₹2.33 Cr | ₹1.87 Cr |
Depreciation | ₹0.40 Cr | ₹0.43 Cr | ₹0.43 Cr | ₹0.41 Cr | ₹0.41 Cr |
Profit Before Taxation & Exceptional Items | ₹0.87 Cr | ₹0.79 Cr | ₹1.02 Cr | ₹1.92 Cr | ₹1.46 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹0.87 Cr | ₹0.79 Cr | ₹1.02 Cr | ₹1.92 Cr | ₹1.46 Cr |
Provision for Tax | ₹0.16 Cr | ₹0.23 Cr | ₹0.32 Cr | ₹0.68 Cr | ₹0.26 Cr |
Current Income Tax | ₹0.24 Cr | ₹0.23 Cr | ₹0.27 Cr | ₹0.33 Cr | ₹0.25 Cr |
Deferred Tax | ₹-0.09 Cr | ₹0.01 Cr | ₹0.04 Cr | ₹0.35 Cr | - |
Other taxes | ₹0.00 Cr | ₹-0.01 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.01 Cr |
Profit After Tax | ₹0.71 Cr | ₹0.56 Cr | ₹0.70 Cr | ₹1.24 Cr | ₹1.21 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹-33 Cr | ₹-33 Cr | ₹-34 Cr | ₹-35 Cr | ₹-36 Cr |
Appropriations | ₹-32 Cr | ₹-33 Cr | ₹-33 Cr | ₹-34 Cr | ₹-35 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | - | ₹-0.03 Cr |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹0.44 | ₹0.34 | ₹0.43 | ₹0.76 | ₹0.74 |
Adjusted EPS | ₹0.44 | ₹0.34 | ₹0.43 | ₹0.76 | ₹0.74 |
Compare Income Statement of peers of BIOFIL CHEMICALS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOFIL CHEMICALS & PHARMACEUTICALS | ₹118.3 Cr | -3.2% | -10.3% | 45.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹453,486.0 Cr | -0.6% | 1.3% | 65.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,321.0 Cr | -1.1% | 11.4% | 64% | Stock Analytics | |
CIPLA | ₹125,852.0 Cr | -2.3% | -6.8% | 33.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,799.0 Cr | 1.5% | 1% | 22.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,726.0 Cr | -4.2% | -8.1% | 72.3% | Stock Analytics |
BIOFIL CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOFIL CHEMICALS & PHARMACEUTICALS | -3.2% |
-10.3% |
45.6% |
SENSEX | -0.7% |
-2.4% |
22% |
You may also like the below Video Courses